Zimbabwe has declined a significant American healthcare agreement worth 367 million US dollars (£272m) over five years due to the United States' request for confidential data.
This move became public after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official spokesperson has since stated that the US was requesting biological samples for scientific study and commercial gain while was unwilling to guarantee the benefits from any future treatments.
"We will now turn to the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged continued dialogue to secure a deal agreeable to both sides so the country's critical HIV treatment initiative can proceed.
Broader Implications
Zimbabwe's decision comes after a similar situation in Kenya, where a court suspended a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost transparency and accountability.
According to statements, 16 African countries have so far signed similar health pacts, representing more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The money for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to share its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," Mangwana explained.
"In essence, our country would supply the basic resources for medical research with no assurance that the final treatments would be accessible to our people if a future disease outbreak emerge."
National Interest and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending structures previously established via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.
"This system is designed to guarantee that when a nation provides its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how future co-operation might be designed in a way that honours the independence and dignity of both nations."
Health Experts Reaction
Medical experts said it acknowledged the government's concerns, but urged that talks need to persist considering much of the nation's HIV programmes relied on international support.
"In cases where technical issues exist, including those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," the group added.
The situation emphasises the ongoing debate between accepting vital foreign assistance and protecting a country's data in an increasingly data-driven world.